The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiac Biomarkers Testing Market Research Report 2025
Synopsis
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
The global Cardiac Biomarkers Testing market was valued at US$ 7132.7 million in 2023 and is anticipated to reach US$ 11410 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
This report aims to provide a comprehensive presentation of the global market for Cardiac Biomarkers Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Biomarkers Testing.
Report Scope
The Cardiac Biomarkers Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Biomarkers Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Biomarkers Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
ROCHE
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
Segment by Type
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Segment by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Biomarkers Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
The global Cardiac Biomarkers Testing market was valued at US$ 7132.7 million in 2023 and is anticipated to reach US$ 11410 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
This report aims to provide a comprehensive presentation of the global market for Cardiac Biomarkers Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Biomarkers Testing.
Report Scope
The Cardiac Biomarkers Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cardiac Biomarkers Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Biomarkers Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
ROCHE
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
Segment by Type
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Segment by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiac Biomarkers Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Myocardial Muscle Creatine Kinase (CK-MB)
1.2.3 Troponins (T and I)
1.2.4 Myoglobin
1.2.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
1.2.6 Ischemia-modified Albumin (IMA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cardiac Biomarkers Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Biomarkers Testing Market Perspective (2019-2030)
2.2 Cardiac Biomarkers Testing Growth Trends by Region
2.2.1 Global Cardiac Biomarkers Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cardiac Biomarkers Testing Historic Market Size by Region (2019-2024)
2.2.3 Cardiac Biomarkers Testing Forecasted Market Size by Region (2025-2030)
2.3 Cardiac Biomarkers Testing Market Dynamics
2.3.1 Cardiac Biomarkers Testing Industry Trends
2.3.2 Cardiac Biomarkers Testing Market Drivers
2.3.3 Cardiac Biomarkers Testing Market Challenges
2.3.4 Cardiac Biomarkers Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Biomarkers Testing Players by Revenue
3.1.1 Global Top Cardiac Biomarkers Testing Players by Revenue (2019-2024)
3.1.2 Global Cardiac Biomarkers Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cardiac Biomarkers Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiac Biomarkers Testing Revenue
3.4 Global Cardiac Biomarkers Testing Market Concentration Ratio
3.4.1 Global Cardiac Biomarkers Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Testing Revenue in 2023
3.5 Cardiac Biomarkers Testing Key Players Head office and Area Served
3.6 Key Players Cardiac Biomarkers Testing Product Solution and Service
3.7 Date of Enter into Cardiac Biomarkers Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Biomarkers Testing Breakdown Data by Type
4.1 Global Cardiac Biomarkers Testing Historic Market Size by Type (2019-2024)
4.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2025-2030)
5 Cardiac Biomarkers Testing Breakdown Data by Application
5.1 Global Cardiac Biomarkers Testing Historic Market Size by Application (2019-2024)
5.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cardiac Biomarkers Testing Market Size (2019-2030)
6.2 North America Cardiac Biomarkers Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cardiac Biomarkers Testing Market Size by Country (2019-2024)
6.4 North America Cardiac Biomarkers Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Biomarkers Testing Market Size (2019-2030)
7.2 Europe Cardiac Biomarkers Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cardiac Biomarkers Testing Market Size by Country (2019-2024)
7.4 Europe Cardiac Biomarkers Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Biomarkers Testing Market Size (2019-2030)
8.2 Asia-Pacific Cardiac Biomarkers Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiac Biomarkers Testing Market Size (2019-2030)
9.2 Latin America Cardiac Biomarkers Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cardiac Biomarkers Testing Market Size by Country (2019-2024)
9.4 Latin America Cardiac Biomarkers Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Biomarkers Testing Market Size (2019-2030)
10.2 Middle East & Africa Cardiac Biomarkers Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Cardiac Biomarkers Testing Introduction
11.1.4 Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Detail
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Introduction
11.2.4 Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Cardiac Biomarkers Testing Introduction
11.3.4 BioMerieux Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.3.5 BioMerieux Recent Development
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Detail
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.4.5 Bio-Rad Laboratories, Inc. Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Detail
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Cardiac Biomarkers Testing Introduction
11.5.4 Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.5.5 Danaher Corporation Recent Development
11.6 ROCHE
11.6.1 ROCHE Company Detail
11.6.2 ROCHE Business Overview
11.6.3 ROCHE Cardiac Biomarkers Testing Introduction
11.6.4 ROCHE Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.6.5 ROCHE Recent Development
11.7 Siemens AG
11.7.1 Siemens AG Company Detail
11.7.2 Siemens AG Business Overview
11.7.3 Siemens AG Cardiac Biomarkers Testing Introduction
11.7.4 Siemens AG Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.7.5 Siemens AG Recent Development
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Detail
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.8.5 Thermo Fisher Scientific, Inc. Recent Development
11.9 PerkinElmer Inc.
11.9.1 PerkinElmer Inc. Company Detail
11.9.2 PerkinElmer Inc. Business Overview
11.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Introduction
11.9.4 PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.9.5 PerkinElmer Inc. Recent Development
11.10 Tosoh Corporation
11.10.1 Tosoh Corporation Company Detail
11.10.2 Tosoh Corporation Business Overview
11.10.3 Tosoh Corporation Cardiac Biomarkers Testing Introduction
11.10.4 Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2019-2024)
11.10.5 Tosoh Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
